Author Archives: Brittany Agro

One to Watch: Q&A with Paul Dyer

By Brittany Agro | Published: December 10, 2009
Paul Dyer, eMedia Director, WeissComm Group (WCG), is already on his way to the top not only on PR News’ 15 to watch list, but also as an emerging leader in the online healthcare landscape. At 26, Paul Dyer has a long list of accolades that most young professionals his age only dream about. As eMedia [...]
Posted in Marketing, People | Tagged , , , , , , , | Leave a comment

Q&A With Renee Tannenbaum

By Brittany Agro | Published: November 20, 2009
One major theme at the HBA leadership conference may be simple for industry to understand but difficult to accept: change or drown. But for Renee Tannenbaum, it was change that worked toward her advantage. And change, combined with her desire to drive improvement in patient care and meet unmet needs, is what led her to [...]
Posted in Events, Strategy | Tagged , , , , , , , , | Leave a comment

Hot Topics at HBA

By Brittany Agro | Published: November 20, 2009
The 2009 Healthcare Businesswomen’s Association leadership conference is officially underway in sunny California. Last night, festivities got underway with a welcome reception for attendees followed by a “Taste of San Francisco,” which featured lively entertainment and regional cuisine. I had the opportunity to catch up with a few seasoned participants who are widely known throughout the [...]
Posted in Events | Tagged , , , | 1 Comment

Roche: New Hires Needed

By Brittany Agro | Published: November 11, 2009
Cheer up, pharma, not all the news is bad! Amidst the worst national job market since the early 1980’s, Roche Pharma Research in Nutley, NJ is looking to hire. Efforts are currently underway to find scientists and support staff in areas such as screening, safety, and bioanalytics. In addition to inflammation, the Nutley operation serves as [...]
Posted in Strategy | Tagged , , , , , , , | Leave a comment

A Lead Drug on the Way? All Eyes on FDA

By Brittany Agro | Published: November 4, 2009
For NeurogesX, a small biopharma company based in San Mateo, CA, time does not stand still. Every day preceding November 16 brings its flagship drug, Qutenza, one step closer to approval. Until then, the company has turned its energies to finalizing its US commercialization strategy. (NeurogesX previously entered into a commercialization agreement with Astellas Pharma [...]
Posted in Strategy | Tagged , , , , | Leave a comment